Sfoglia per Autore
DIABETIC NEUROPATHY IN THE RAT .1. ALCAR AUGMENTS THE REDUCED LEVELS AND AXOPLASMIC-TRANSPORT OF SUBSTANCE-P
1995 A. DIGIULIO, E. LESMA, A. GORIO
Perinatal morphine .2. Changes in cortical plasticity
1995 E. Germani, E. Lesma, S. DeBiasi, A. Di Giulio, A. Bertelli, A. Gorio
Perinatal morphine.II: changes in cortical plasticity
1995 E. Germani, E. Lesma, S. De Biasi, A.M. Di Giulio, A. Bertelli, A. Gorio
High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells
1996 B. Tenconi, E. Lesma, A. Di Giulio, A. Gorio
Perinatal exposure to morphine: Reactive changes in the brain after 6-hydroxydopamine
1996 A. Gorio, L. Vergani, M. Malosio, E. Lesma, A. Di Giulio
Molecular characterization of a glycosylphosphatidylinositol-linked ADP-ribosyltransferase from lymphocytes
1996 I.J. Okazaki, H.J. Kim, N.G. Mcelvaney, E. Lesma, J. Moss
Glycosaminoglycans in nerve injury .1. Low doses of glycosaminoglycans promote neurite formation
1996 E. Lesma, A. Di Giulio, L. Ferro, G. Prino, A. Gorio
Glycosaminoglycan supplementation promotes nerve regeneration and muscle reinnervation
1997 A. Gorio, E. Lesma, L. Vergani, A. Di Giulio
Neuroprotection, neuroregeneration, and interaction with insulin-like growth factor-I: Novel non-anticoagulant action of glycosaminoglycans
1998 A. Gorio, L. Vergani, E. Lesma, A. Di Giulio
Characterization of HDLbound and soluble RT6 released following administration of anti-RT6.1 monoclonal antibody
1998 E. Lesma, J. Moss, J.B. Brewer, R. Bortell, J.P. Mordes, D.L. Greiner, A.A. Rossini
Inhibition of high glucose-induced protein mono-ADP-ribosylation restores neuritogenesis and sodium-pump activity in SY5Y neuroblastoma cells
1999 A. Di Giulio, E. Lesma, E. Germani, A. Gorio
Progressive and selective changes in neurotrophic factor expression and substance P axonal transport induced by perinatal diabetes: Protective action of antioxidant treatment
1999 E. Germani, E. Lesma, A. Di Giulio, A. Gorio
Long term neuroprotective effects of glycosaminoglycan-IGF-I cotreatment in the neuromuscular disease of the Mnd mouse
1999 A. Gorio, E. Germani, E. Lesma, D. Farina, F. Cozzi, E. Muller, A. Di Giulio
Long-term neuroprotective effects of glycosaminoglycans-IGF-I cotreatment in the motor neuron degeneration (mnd) mutant mouse
1999 A. Gorio, E. Germani, E. Lesma, G. Rossoni, E. Muller, A. Di Giulio
Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: Blockade of motor neuron death in the wobbler mouse
1999 L. Vergani, M. Losa, E. Lesma, A. Di Giulio, A. Torsello, E. Muller, A. Gorio
Glycosaminoglycans treatment increases IGF-I muscle levels and counteracts motor neuron death : a novel nonanticoagulant action
1999 M. Losa, L. Vergani, E. Lesma, G. Rossoni, A. Di Giulio, A. Vercelli, A. Torsello, E. Muller, A. Gorio
Characterization of NAD:arginine ADP-ribosyltransferases
1999 J. Moss, E. Balducci, E. Cavanaugh, H-J Kim, P. Konczalik, E. Lesma, I.J. Okazaki, M. Park, M. Shoemaker, L.A. Stevens, A. Zolkiewska
Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review
2000 A.M. Di Giulio, E. Germani, E. Lesma, E. Muller, A. Gorio
Levels of Art2+ cells but not soluble Art2 protein correlate with expression of autoimmune diabetes in the BB rat
2001 R. Bortel, D.J. Waite, B.J. Whalen, D. Todd, J.H. Leif, E. Lesma, J. Moss, J.P. Mordes, A.A. Rossini, D.L. Greiner
Co-administration of IGF-I and glycosaminoglycans greatly delays motor neuron disease and affects IGF-I expression in the wobbler mouse : a long term study
2002 A. Gorio, E.A. Lesma, L. Madaschi, A.M. Di Giulio
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile